many of these new technologies are headed straight for the consumer market, pitched by companies such as Knome, 23andMe, and deCode. The promise, proponents say, is that widespread genome mapping will result in better, more-personalized medical care....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to $99,000 to see your future?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account